BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Enterobiasis

Below is an extended Enterobiasis patents listing. Click here to return to the Enterobiasis main in depth entry.

Patents :

US Patent No.Title
6994977 Method of identifying inhibitors of C--C chemokine receptor 3
7163937 Cyclic derivatives as modulators of chemokine receptor activity
7166614 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
7183270 Cyclic derivatives as modulators of chemokine receptor activity
7183273 Chemokine receptor binding heterocyclic compounds
7214703 Pyrrolidinohydrochinazolines
7230008 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
7230022 Substituted fused bicyclic amines as modulators of chemokine receptor activity
7230133 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
7238711 Compounds and methods to inhibit or augment an inflammatory response
7247725 Gamma-aminoamide modulators of chemokine receptor activity
7157471 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
7125895 Cyclic amine derivatives and their uses
7001718 Method of inhibiting pathogenicity of infectious agents
7012133 Antibodies to C-C chemokine Receptor 3 Protein
7022717 Chemokine receptor binding heterocyclic compounds
7045521 Cyclic derivatives as modulators of chemokine receptor activity
7067117 Compounds and methods to inhibit or augment an inflammatory response
7084155 Chemokine receptor binding heterocyclic compounds
7087604 Cyclic derivatives as modulators of chemokine receptor activity
7091211 Cyclopentyl modulators of chemokine receptor activity
7091217 Chemokine receptor binding heterocyclic compounds
7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
7265201 Human chemotactic cytokine
7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
7381738 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
7390803 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity
7396840 Chemokine receptor binding heterocyclic compounds
7402657 C-C chemokine receptor 3 proteins
7410961 2,6-disubstituted piperiddines as modulators
7413866 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
7419996 Parenteral and oral formulations of benzimidazoles
7423129 Antibodies to human eotaxin
7354934 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
7351720 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
7285620 Human chemotactic cytokine
7288563 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
7291615 Cyclic derivatives as modulators of chemokine receptor activity
7291631 CXCR4 chemokine receptor binding compounds
7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
7294647 Kappa agonist compounds and pharmaceutical formulations thereof
7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
7312234 Chemokine receptor binding heterocyclic compounds
7317019 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
7338947 Cyclic derivatives as modulators of chemokine receptor activity
7442512 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.